Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

Satsuma, a unit of a Japanese drugmaker with U.S. headquarters in Durham, said its treatment, called Atzumi, received its new ...

For J&J, there was a positive outcome as the Oncologic Drugs Advisory Committee (ODAC) voted six to two in favour of approval ...

The initiatives reflect the latest measures from federal agencies to reduce and ultimately replace animal testing in drug development and ...

The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...

Heralding an evolution of the blood pressure monitoring experience, heart health leader OMRON Healthcare today introduced ...

Shares of biotech company UroGen Pharma Ltd. (URGN) plummeted 48% on Wednesday noon after the company said that a committee ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

We learn how the EU’s new Clinical Trial Regulation (CTR) and the CTIS platform are reshaping clinical trial approvals and ...

On May 16, 2024, the CDE’s official website announced that the Application would be reviewed via the priority review and approval process. This marks the fourth sac-TMT indication to go through the ...

Researchers have detailed the physics behind a phenomenon that allows them to create spin in liquid droplets using ultrasound waves, which concentrates solid particles suspended in the liquid. The ...

If you’re anything like me, what finally made you stop rolling your eyes at the term “artificial intelligence” was OpenAI’s ...